Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Price to Book Value: 108.42 for March 11, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 11, 2024 | 108.42 |
| March 08, 2024 | 108.42 |
| March 07, 2024 | 108.33 |
| March 06, 2024 | 108.23 |
| March 05, 2024 | 108.23 |
| March 04, 2024 | 108.19 |
| March 01, 2024 | 108.09 |
| February 29, 2024 | 108.09 |
| February 28, 2024 | 108.14 |
| February 27, 2024 | 108.09 |
| February 26, 2024 | 108.05 |
| February 23, 2024 | 108.05 |
| February 22, 2024 | 108.19 |
| February 21, 2024 | 106.59 |
| February 20, 2024 | 105.50 |
| February 16, 2024 | 105.64 |
| February 15, 2024 | 105.69 |
| February 14, 2024 | 105.78 |
| February 13, 2024 | 105.88 |
| February 12, 2024 | 106.26 |
| February 09, 2024 | 105.78 |
| February 08, 2024 | 105.27 |
| February 07, 2024 | 105.22 |
| February 06, 2024 | 105.31 |
| February 05, 2024 | 83.42 |
| Date | Value |
|---|---|
| February 02, 2024 | 83.34 |
| February 01, 2024 | 83.27 |
| January 31, 2024 | 83.34 |
| January 30, 2024 | 83.49 |
| January 29, 2024 | 83.60 |
| January 26, 2024 | 83.60 |
| January 25, 2024 | 83.60 |
| January 24, 2024 | 83.57 |
| January 23, 2024 | 83.60 |
| January 22, 2024 | 83.38 |
| January 19, 2024 | 84.01 |
| January 18, 2024 | 83.98 |
| January 17, 2024 | 83.75 |
| January 16, 2024 | 83.68 |
| January 12, 2024 | 83.60 |
| January 11, 2024 | 83.79 |
| January 10, 2024 | 83.79 |
| January 09, 2024 | 83.45 |
| January 08, 2024 | 83.45 |
| January 05, 2024 | 39.34 |
| January 04, 2024 | 39.94 |
| January 03, 2024 | 39.26 |
| January 02, 2024 | 41.02 |
| December 29, 2023 | 42.40 |
| December 28, 2023 | 42.66 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.063
Minimum
Sep 29 2022
108.42
Maximum
Mar 08 2024
11.71
Average
4.715
Median
Price to Book Value Benchmarks
| Merck & Co Inc | 5.621 |
| Axonics Inc | 5.421 |
| Johnson & Johnson | 5.234 |
| Boston Scientific Corp | 6.274 |
| Ambrx Biopharma Inc (DELISTED) | 7.292 |
Price to Book Value Related Metrics
| PS Ratio | 2.282 |
| Price | 23.01 |
| Earnings Yield | -38.07% |